Results 141 to 150 of about 36,030 (253)

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

Journal of Translational Medicine, 2010
It is well established that HIV-1 infection typically involves an interaction between the viral envelope protein gp120/41 and the CD4 molecule followed by a second interaction with a chemokine receptor, usually CCR5 or CXCR4.
Cicala Claudia, Arthos James, Fauci Anthony   +2 more
doaj  

Mass Spectrometric Characterization of a Discontinuous Epitope of the HIV Envelope Protein HIV-gp120 Recognized by the Human Monoclonal Antibody 1331A1

Journal of Immunology, 2000
E. Hochleitner, M. Gorny, S. Zolla-Pazner, K. Tomer   +3 more
semanticscholar   +1 more source

Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.

Journal of Clinical Investigation, 1994
S. Pincus, K. Messer, P. Nara, W. Blattner, G. Colclough, M. Reitz   +5 more
semanticscholar   +1 more source

Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. [PDF]

Viruses
Wu G, Sardo L, Li Y, Heron SD, Shyong B, Mazur M, Gorman DM, Balibar CJ, Magliaro BC, Leach C, Rush T, Howell BJ.   +11 more
europepmc   +1 more source

LncRNA SNHG1 Knockdown Ameliorates HIV-1 gp120V3 Loop-Induced Microglial Neuroinflammation by Regulating the Autophagy Process. [PDF]

Inflammation
Yan X, Zuo Q, Li X, Liu Y, Wang L, Gan L, He H, Wen S, Tang H, Wang H, Pan R, Fu Y, Dong J.   +12 more
europepmc   +1 more source

Glycoform-Dependent Antigenicity in gp120 of HIV-1 Envelope Protein

Trends in Glycoscience and Glycotechnology, 2014
openaire   +2 more sources

Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.

Glycobiology, 2005
A. Pashov, S. Macleod, Rinku Saha, M. Perry, T. Vancott, T. Kieber‐Emmons   +5 more
semanticscholar   +1 more source

ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. [PDF]

NPJ Vaccines
Shrivastava S, Carmen JM, Kim J, Peachman KK, Basu S, Alving R, Nettere D, Kundu G, Yum L, Rahman MA, Jha S, Trinh HV, Rosado L, Nguyen P, Morrison E, Swafford I, Machmach K, Bolton JS, Yates A, Misicka E, Beck Z, Mutascio S, Jobe O, Zemil McCrea M, Wieczorek L, Bergmann-Leitner ES, Polonis V, Paquin-Proulx D, Pollara J, Matyas GR, Alving CR, Thomas R, Franchini G, Ferrari G, Haynes BF, Ake JA, Rao M.   +36 more
europepmc   +1 more source

Comparison of Immune Responses Elicited by Ad5F35-AEgp145 Alone or in Combination with rMVA-AEgp145. [PDF]

Viruses
Yang J, Ma Q, He X, Li H, Zhang X, Hao Y, Feng X.   +6 more
europepmc   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source